These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 31492643

  • 1. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 2. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [Abstract] [Full Text] [Related]

  • 3. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop F, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial group.
    Gut; 2019 Sep; 68(9):1613-1623. PubMed ID: 30971419
    [Abstract] [Full Text] [Related]

  • 4. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.
    Everitt H, Landau S, Little P, Bishop FL, McCrone P, O'Reilly G, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial team.
    BMJ Open; 2015 Jul 15; 5(7):e008622. PubMed ID: 26179651
    [Abstract] [Full Text] [Related]

  • 5. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.
    Health Technol Assess; 2006 Jun 15; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
    McCrone P, Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    BMC Gastroenterol; 2021 Jul 06; 21(1):276. PubMed ID: 34229619
    [Abstract] [Full Text] [Related]

  • 7. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, Medford N, McCrone P, Murray J, Richardson MP, Pilecka I, Eastwood C, Moore M, Mosweu I, Perdue I, Landau S, Chalder T, CODES study group.
    Lancet Psychiatry; 2020 Jun 06; 7(6):491-505. PubMed ID: 32445688
    [Abstract] [Full Text] [Related]

  • 8. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
    Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, Vas Falcao A, Landau S, O'Reilly G, Windgassen S, Holland R, Little P, McCrone P, Goldsmith K, Coleman N, Logan R, Bishop FL.
    J Med Internet Res; 2020 Nov 20; 22(11):e18691. PubMed ID: 33216002
    [Abstract] [Full Text] [Related]

  • 9. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M, Saxon D, Hardy GE, Bradburn M, Galloway D, Wickramasekera N, Keetharuth AD, Bower P, King M, Elliott R, Gabriel L, Kellett S, Shaw S, Wilkinson T, Connell J, Harrison P, Ardern K, Bishop-Edwards L, Ashley K, Ohlsen S, Pilling S, Waller G, Brazier JE.
    Lancet Psychiatry; 2021 Jun 20; 8(6):487-499. PubMed ID: 34000240
    [Abstract] [Full Text] [Related]

  • 10. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe S, French P, Hutton P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TR, Davies L, Shields G, Buck D, Tully S, Kingdon D.
    Health Technol Assess; 2019 Feb 20; 23(7):1-144. PubMed ID: 30806619
    [Abstract] [Full Text] [Related]

  • 11. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.
    Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P.
    BMC Gastroenterol; 2013 Apr 21; 13():68. PubMed ID: 23602047
    [Abstract] [Full Text] [Related]

  • 12. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT, Sibelli A, Moss-Morris R, van Tilburg MAL, Levy RL, Oser M.
    Neurogastroenterol Motil; 2021 Nov 21; 33(11):e14108. PubMed ID: 33745228
    [Abstract] [Full Text] [Related]

  • 13. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.
    Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H, Furukawa TA.
    BMC Gastroenterol; 2020 Feb 04; 20(1):29. PubMed ID: 32019509
    [Abstract] [Full Text] [Related]

  • 14. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Lackner JM, Jaccard J, Radziwon CD, Firth RS, Gudleski GD, Hamilton F, Katz LA, Keefer L, Krasner SS, Ma CX, Sitrin MD, Brenner DM.
    Am J Gastroenterol; 2019 Feb 04; 114(2):330-338. PubMed ID: 30429592
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M, Miguez S, Dukas B, Onwude O, White S.
    JMIR Mhealth Uhealth; 2021 May 20; 9(5):e26152. PubMed ID: 33872182
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
    Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ.
    Psychol Med; 2010 Jan 20; 40(1):85-94. PubMed ID: 19531276
    [Abstract] [Full Text] [Related]

  • 17. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA, ATLANTIS trialists.
    Lancet; 2023 Nov 11; 402(10414):1773-1785. PubMed ID: 37858323
    [Abstract] [Full Text] [Related]

  • 18. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 19. Patients' perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care.
    Sibelli A, Moss-Morris R, Chalder T, Bishop FL, Windgassen S, Everitt H.
    Br J Gen Pract; 2018 Sep 18; 68(674):e654-e662. PubMed ID: 30061195
    [Abstract] [Full Text] [Related]

  • 20. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Hamilton FA, Katz LA, Krasner SS, Ma CX, Radziwon CD, Sitrin MD.
    Gastroenterology; 2018 Jul 18; 155(1):47-57. PubMed ID: 29702118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.